Skip to main content
Caplight Logo









O2 RegenTech

O2 RegenTech

Private
Akron, OhioHealthcare & Life Scienceshttps://o2regentech.com

Last Round

Crowdfunding

Apr 22, 2024

Total Funding Raised

$917,800

Company Overview

O2 RegenTech operates in Healthcare & Life Sciences and is based in Akron, Ohio. Its latest recorded funding round was a Grant round in June 2017.

O2 RegenTech is a medical device company that develops oxygen-releasing, moisture-retentive, and antimicrobial wound dressings for chronic wound care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

O2 RegenTech Comparables

Compare O2 RegenTech with similar companies based on industry and business-model similarity.

O2 RegenTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imbed Biosciences
83%
EO2 Concepts
81%
Hemarina
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

O2 RegenTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingApr 22, 2024
GrantJun 26, 2017
GrantMay 16, 2017
GrantJan 26, 2017
GrantDec 11, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

O2 RegenTech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2024

    $612K raised from Netcapital.

  • Jun 26, 2017

    $100K grant from Lorain County Community College Innovation Fund.

Book a demo to see all signals

For institutional investors. Book with your work email.

O2 RegenTech Filings

Explore SEC and related filing metadata, where available.

O2 RegenTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about O2 RegenTech's valuation, stock price, and market status.

Is O2 RegenTech a public or private company?

O2 RegenTech is a private company.

What is the current stock price of O2 RegenTech?

O2 RegenTech is a private company, so its shares have no public market price. Caplight tracks O2 RegenTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is O2 RegenTech worth (valuation)?

Valuation information for O2 RegenTech is not publicly available.

Can I buy O2 RegenTech stock?

O2 RegenTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was O2 RegenTech's last funding round?

O2 RegenTech's most recent funding round was Crowdfunding on April 22, 2024.

Who are the main investors in O2 RegenTech?

Key investors in O2 RegenTech include Lorain County Community College Innovation Fund, NIH RADx, Ohio Third Frontier, Netcapital, National Science Foundation.

Will O2 RegenTech IPO soon?

No public IPO plans have been announced for O2 RegenTech.

How can I track O2 RegenTech secondary market activity?

Caplight tracks bids, offers, and trades in O2 RegenTech's shares on secondary markets.

Firmographic Details

HeadquartersAkron, Ohio
Employee Range1
Year Founded2017
Last FundingApr 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?